Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 34 (SLC25A34) is a protein localized to the inner mitochondrial membrane and is a member of the mitochondrial carrier SLC25 family[1][6][7]. It functions as a putative antiporter, presumably exchanging dicarboxylates and sulfur oxoanions across the mitochondrial inner membrane, and may contribute to intracellular metabolite exchange and energy homeostasis[3][6]. While SLC25A34 shares homology with other functionally characterized mitochondrial transporters, its specific substrates and biological roles remain poorly characterized, and there is limited direct evidence linking it to particular physiological or pathological conditions[5][7]. The SLC25 family as a whole is essential for mitochondrial metabolism, transporting various metabolites, nucleotides, and co-factors, and some members have established roles in cancer metabolism, apoptosis, and metabolic homeostasis; however, SLC25A34 itself is currently under-characterized, with no direct links to drug interactions, biomarker status, or specific disease mechanisms in the available literature[2][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 34 (SLC25A34).